Decreased CDC45 protein expression correlated with the progression and poor prognosis in HCC, indicating that CDC45 is a valuable promising prognostic biomarker and might be a potential treatment target in HCC. This evidence concerns the gene CDC45 and hepatocellular carcinoma.